Chang Kwon Kim, M.D.,F.A.C.S. Surgery Medicare: Not Enrolled in Medicare Practice Location: 0n300 Armstrong Ln, Geneva, IL 60134 Phone: 630-208-1700 |
Katherine Hansen, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 304 Randall Rd, Geneva, IL 60134 Phone: 630-307-7799 Fax: 630-307-2277 |
Narha Lee, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2631 Williamsburg Ave, Suite 202, Geneva, IL 60134 Phone: 630-208-7500 Fax: 630-208-7501 |
Mary Ahn, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 351 Delnor Dr, Geneva, IL 60134 Phone: 630-307-7799 Fax: 630-307-2277 |
Dean P Shoener, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1665 South St, Geneva, IL 60134 Phone: 630-208-7874 Fax: 630-208-7880 |
Ms. Connie H Keung, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 351 Delnor Dr Ste 400, Geneva, IL 60134 Phone: 630-668-0833 Fax: 630-208-4373 |
Dr. Jaclyn Beth Wierzbicki, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 351 Delnor Dr, Geneva, IL 60134 Phone: 630-668-0833 Fax: 630-208-4373 |
Michele I Slogoff, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1665 South St, Geneva, IL 60134 Phone: 630-208-7874 Fax: 630-208-7880 |
Andrew J Kramer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1665 South St, Geneva, IL 60134 Phone: 630-208-7874 Fax: 630-208-7880 |
Dr. David Joseph Ryan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 351 Delnor Dr Ste 400, Geneva, IL 60134 Phone: 630-668-0833 Fax: 630-208-4373 |
Jennifer Hein, Surgery - Plastic and Reconstructive Surgery Medicare: Not Enrolled in Medicare Practice Location: 2631 Williamsburg Ave Ste 102, Geneva, IL 60134 Phone: 630-232-7860 |
News Archive
BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease). The company expects to begin Phase I clinical studies in 2010.
Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs.
A strategy developed by Massachusetts General Hospital (MGH) researchers to shield the ovaries of female mammals from the damaging effects of radiation and chemotherapy has passed an important milestone. A collaborative study with investigators from Oregon Health and Sciences University (OHSU), published online in the journal Fertility and Sterility, reports that brief preexposure of the ovaries to an FDA-approved agent called FTY720 preserved the fertility of female rhesus monkeys exposed to potentially lethal doses of radiation.
Results of a phase one trial show that an investigational topical drug, resiquimod gel, causes regression of both treated and untreated tumor lesions and may completely remove cancerous cells from both sites in patients with early stage cutaneous T cell lymphoma (CTCL) - a rare type of non-Hodgkin lymphoma that affects the skin.
› Verified 2 days ago